Trabajos de Mafalda Oliveira

Clinical Medicine


  Listando 43 trabajos del autor/autora 38
Lista de trabajos en el área Clinical Medicine
Mentions   0   Wikipedia   60   News   0   Policy
Article HER2-enriched subtype as a predictor of pathological complete response following trastuzumab and lapatinib without chemotherapy in early-stage HER2-positive breast cancer (PAMELA): an open-label, single-group, multicentre, phase 2 trial Llombart-Cussac, Antonio; Cortes, Javier; Pare, Laia; Galvan, Patricia; Bermejo, Begona; Martinez, Noelia; Vidal, Maria; Pernas, Sonia; Lopez, Rafael; Munoz, Montserrat; Nuciforo, Paolo; Morales, Serafin; Oliveira, Mafalda; de la Pena, Lorena; Pelaez, Alex LANCET ONCOLOGY 1470-2045 (2017) DOI / 10.1016/s1470-2045(17)30021-9
Mentions   0   Wikipedia   37   News   0   Policy
Article A predictive model of pathologic response based on tumor cellularity and tumor-infiltrating lymphocytes (CelTIL) in HER2-positive breast cancer treated with chemo-free dual HER2 blockade Nuciforo, P.; Pascual, T.; Cortes, J.; Llombart-Cussac, A.; Fasani, R.; Pare, L.; Oliveira, M.; Galvan, P.; Martinez, N.; Bermejo, B.; Vidal, M.; Pernas, S.; Lopez, R.; Munoz, M.; Garau, I.; Manso, L.; Alarcon, J.; Martinez, E.; Rodrik-Outmezguine, V.; Bra ANNALS OF ONCOLOGY 0923-7534 (2018) DOI / 10.1093/annonc/mdx647 Bronze
Mentions   0   Wikipedia   28   News   0   Policy
Article Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer Bardia, A.; Hurvitz, S. A.; Tolaney, S. M.; Loirat, D.; Punie, K.; Oliveira, M.; Brufsky, A.; Sardesai, S. D.; Kalinsky, K.; Zelnak, A. B.; Weaver, R.; Traina, T.; Dalenc, F.; Aftimos, P.; Lynce, F.; Diab, S.; Cortes, J.; O'shaughnessy, J.; Dieras, V; Ferr NEW ENGLAND JOURNAL OF MEDICINE 0028-4793 (2021) DOI / 10.1056/nejmoa2028485
Mentions   0   Wikipedia   32   News   0   Policy
Article Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With >= 2 HER2-Directed Regimens: Phase III NALA Trial Saura, Cristina; Oliveira, Mafalda; Feng, Yin-Hsun; Dai, Ming-Shen; Chen, Shang-Wen; Hurvitz, Sara A.; Kim, Sung-Bae; Moy, Beverly; Delaloge, Suzette; Gradishar, William; Masuda, Norikazu; Palacova, Marketa; Trudeau, Maureen E.; Mattson, Johanna; Yap, Yoon JOURNAL OF CLINICAL ONCOLOGY 0732-183X (2020) DOI / 10.1200/jco.20.00147 Gold other, Green published
Mentions   0   Wikipedia   9   News   0   Policy
Article Ribociclib plus letrozole versus chemotherapy for postmenopausal women with hormone receptor-positive, HER2-negative, luminal B breast cancer (CORALLEEN): an open-label, multicentre, randomised, phase 2 trial Prat, Aleix; Saura, Cristina; Pascual, Tomas; Hernando, Cristina; Munoz, Montserrat; Pare, Laia; Gonzalez Farre, Blanca; Fernandez, Pedro L.; Galvan, Patricia; Chic, Nuria; Gonzalez Farre, Xavier; Oliveira, Mafalda; Gil-Gil, Miguel; Arumi, Miriam; Ferrer, LANCET ONCOLOGY 1470-2045 (2020) DOI / 10.1016/s1470-2045(19)30786-7
Mentions   0   Wikipedia   14   News   1   Policy
Article Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial Kim, Sung-Bae; Dent, Rebecca; Im, Seock-Ah; Espie, Marc; Blau, Sibel; Tan, Antoinette R.; Isakoff, Steven J.; Oliveira, Mafalda; Saura, Cristina; Wongchenko, Matthew J.; Kapp, Amy V.; Chan, Wai Y.; Singel, Stina M.; Maslyar, Daniel J.; Baselga, Jose LANCET ONCOLOGY 1470-2045 (2017) DOI / 10.1016/s1470-2045(17)30450-3 Green accepted
Mentions   0   Wikipedia   0   News   0   Policy
Article Palbociclib and Trastuzumab in HER2-Positive Advanced Breast Cancer: Results from the Phase II SOLTI-1303 PATRICIA Trial Ciruelos, Eva; Villagrasa, Patricia; Pascual, Tomas; Oliveira, Mafalda; Pernas, Sonia; Pare, Laia; Escriva-de-Romani, Santiago; Manso, Luis; Adamo, Barbara; Martinez, Eduardo; Cortes, Javier; Vazquez, Silvia; Perello, Antonia; Garau, Isabel; Mele, Mireia; CLINICAL CANCER RESEARCH 1078-0432 (2020) DOI / 10.1158/1078-0432.ccr-20-0844
Mentions   0   Wikipedia   7   News   0   Policy
Article Metabolic Imaging Detects Resistance to PI3K alpha Inhibition Mediated by Persistent FOXM1 Expression in ER+ Breast Cancer Ros, Susana; Wright, Alan J.; D'Santos, Paula; Hu, De-en; Hesketh, Richard L.; Lubling, Yaniv; Georgopoulou, Dimitra; Lerda, Giulia; Couturier, Dominique-Laurent; Razavi, Pedram; Pelossof, Rapahel; Batra, Ankita S.; Mannion, Elizabeth; Lewis, David Y.; Mar CANCER CELL 1535-6108 (2020) DOI / 10.1016/j.ccell.2020.08.016 Gold other, Green accepted
Mentions   0   Wikipedia   5   News   0   Policy
Article HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade Prat, Aleix; Pascual, Tomas; De Angelis, Carmine; Gutierrez, Carolina; Llombart-Cussac, Antonio; Wang, Tao; Cortes, Javier; Rexer, Brent; Pare, Laia; Forero, Andres; Wolff, Antonio C.; Morales, Serafin; Adamo, Barbara; Braso-Maristany, Fara; Vidal, Maria; JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE 0027-8874 (2020) DOI / 10.1093/jnci/djz042 Green published, Bronze
Mentions   0   Wikipedia   1   News   0   Policy
Article TNeoadjuvant letrozole plus taselisib versus letrozole plus placebo in postmenopausal women with oestrogen receptor-positive, HER2-negative, early-stage breast cancer (LORELEI): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial Saura, Cristina; Hlauschek, Dominik; Oliveira, Mafalda; Zardavas, Dimitrios; Jallitsch-Halper, Anita; de la Pena, Lorena; Nuciforo, Paolo; Ballestrero, Alberto; Dubsky, Peter; Lombard, Janine M.; Vuylsteke, Peter; Castaneda, Carlos A.; Colleoni, Marco; Bor LANCET ONCOLOGY 1470-2045 (2019) DOI / 10.1016/s1470-2045(19)30334-1
Mentions   0   Wikipedia   0   News   0   Policy
Article Oestrogen receptor activity in hormone-dependent breast cancer during chemotherapy Chic, Nuria; Schettini, Francesco; Braso-Maristany, Fara; Sanfeliu, Esther; Adamo, Barbara; Vidal, Maria; Martinez, Debora; Galvan, Patricia; Gonzalez-Farre, Blanca; Cortes, Javier; Gavila, Joaquin; Saura, Cristina; Oliveira, Mafalda; Pernas, Sonia; Martin EBIOMEDICINE 2352-3964 (2021) DOI / 10.1016/j.ebiom.2021.103451 Green published, Gold
Mentions   0   Wikipedia   0   News   0   Policy
Article Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade Braso-Maristany, Fara; Griguolo, Gaia; Pascual, Tomas; Pare, Laia; Nuciforo, Paolo; Llombart-Cussac, Antonio; Bermejo, Begona; Oliveira, Mafalda; Morales, Serafin; Martinez, Noelia; Vidal, Maria; Adamo, Barbara; Martinez, Olga; Pernas, Sonia; Lopez, Rafael NATURE COMMUNICATIONS (2020) DOI / 10.1038/s41467-019-14111-3 Gold DOAJ, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Capturing Hyperprogressive Disease with Immune-Checkpoint Inhibitors Using RECIST 1.1 Criteria Matos, Ignacio; Martin-Liberal, Juan; Garcia-Ruiz, Alonso; Hierro, Cinta; Ochoa de Olza, Maria; Viaplana, Cristina; Azaro, Analia; Vieito, Maria; Brana, Irene; Mur, Gemma; Ros, Javier; Mateos, Jose; Villacampa, Guillermo; Berche, Roger; Oliveira, Mafalda; CLINICAL CANCER RESEARCH 1078-0432 (2020) DOI / 10.1158/1078-0432.ccr-19-2226 Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article Evolving Landscape of Molecular Prescreening Strategies for Oncology Early Clinical Trials Dienstmann, Rodrigo; Garralda, Elena; Aguilar, Susana; Sala, Gemma; Viaplana, Cristina; Ruiz-Pace, Fiorella; Gonzalez-Zorelle, Jenifer; Grazia LoGiacco, Deborah; Ogbah, Zighereda; Ramos Masdeu, Laia; Mancuso, Francesco; Fasani, Roberta; Jimenez, Jose; Mart JCO PRECISION ONCOLOGY (2020) DOI / 10.1200/po.19.00398 Gold other, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article SOLTI-1805 TOT-HER3 Study Concept: A Window-of-Opportunity Trial of Patritumab Deruxtecan, a HER3 Directed Antibody Drug Conjugate, in Patients With Early Breast Cancer Pascual, Tomas; Oliveira, Mafalda; Ciruelos, Eva; Bellet Ezquerra, Meritxell; Saura, Cristina; Gavila, Joaquin; Pernas, Sonia; Munoz, Montserrat; Vidal, Maria J.; Margeli Vila, Mireia; Cejalvo, Juan M.; Gonzalez-Farre, Blanca; Espinosa-Bravo, Martin; Cruz, FRONTIERS IN ONCOLOGY 2234-943X (2021) DOI / 10.3389/fonc.2021.638482 Gold DOAJ, Green published
Mentions   0   Wikipedia   2   News   0   Policy
Article Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer Bardia, A.; Tolaney, S. M.; Punie, K.; Loirat, D.; Oliveira, M.; Kalinsky, K.; Zelnak, A.; Aftimos, P.; Dalenc, F.; Sardesai, S.; Hamilton, E.; Sharma, P.; Recalde, S.; Gil, E. C.; Traina, T.; O'shaughnessy, J.; Cortes, J.; Tsai, M.; Vahdat, L.; Dieras, V; ANNALS OF ONCOLOGY 0923-7534 (2021) DOI / 10.1016/j.annonc.2021.06.002 Green published, Hybrid
Mentions   0   Wikipedia   0   News   0   Policy
Article Early ctDNA dynamics as a surrogate for progression-free survival in advanced breast cancer in the BEECH trial Hrebien, S.; Garcia-Murillas, I; Cutts, R.; Fenwick, K.; McEwen, R.; Ratnayake, J.; Maudsley, R.; Carr, T. H.; de Bruin, E. C.; Schiavon, G.; Oliyeira, M.; Turner, N. ANNALS OF ONCOLOGY 0923-7534 (2019) DOI / 10.1093/annonc/mdz085 Gold other, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Independent Validation of the PAM50-Based Chemo-Endocrine Score (CES) in Hormone Receptor-Positive HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2-Based Therapy Pascual, Tomas; Fernandez-Martinez, Aranzazu; Tanioka, Maki; Dieci, M. Vittoria; Pernas, Sonia; Gavila, Joaquin; Guarnieri, Valentina; Cortes, Javier; Villagrasa, Patricia; Chic, Nuria; Vidal, Maria; Adamo, Barbara; Munoz, Montserrat; Griguolo, Gaia; Llomb CLINICAL CANCER RESEARCH 1078-0432 (2021) DOI / 10.1158/1078-0432.ccr-20-4102 Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article SOLTI-1503 PROMETEO TRIAL: combination of talimogene laherparepvec with atezolizumab in early breast cancer Pascual, Tomas; Cejalvo, Juan M.; Oliveira, Mafalda; Vidal, Maria; Vega, Estela; Ganau, Sergi; Julve, Ana; Zamora, Esther; Miranda, Ignacio; Delgado, Ana; Bermejo, Begona; de la Cruz-Merino, Luis; Juan, Manel; Ferrero-Cafiero, Juan M.; Canes, Jordi; Gonzal FUTURE ONCOLOGY 1479-6694 (2020) DOI / 10.2217/fon-2020-0246
Mentions   0   Wikipedia   0   News   0   Policy
Article The AURORA pilot study for molecular screening of patients with advanced breast cancer-a study of the breast international group Maetens, Marion; Brown, David; Irrthum, Alexandre; Aftimos, Philippe; Viale, Giuseppe; Loibl, Sibylle; Laes, Jean-Francois; Campbell, Peter J.; Thompson, Alastair; Cortes, Javier; Seiler, Sabine; Vinnicombe, Sara; Oliveira, Mafalda; Rothe, Francoise; Barec NPJ BREAST CANCER (2017) DOI / 10.1038/s41523-017-0026-6 Green published, Gold other
Mentions   0   Wikipedia   0   News   0   Policy
Article Safety, activity, and molecular heterogeneity following neoadjuvant non-pegylated liposomal doxorubicin, paclitaxel, trastuzumab, and pertuzumab in HER2-positive breast cancer (Opti-HER HEART): an open-label, single-group, multicenter, phase 2 trial Gavila, Joaquin; Oliveira, Mafalda; Pascual, Tomas; Perez-Garcia, Jose; Gonzalez, Xavier; Canes, Jordi; Pare, Laia; Calvo, Isabel; Ciruelos, Eva; Munoz, Montserrat; Virizuela, Juan A.; Ruiz, Isabel; Andres, Raquel; Perello, Antonia; Martinez, Jeronimo; Mor BMC MEDICINE 1741-7015 (2019) DOI / 10.1186/s12916-018-1233-1 Green published, Gold
Mentions   0   Wikipedia   0   News   0   Policy
Article Genetic Alterations in the PI3K/AKT Pathway and Baseline AKT Activity Define AKT Inhibitor Sensitivity in Breast Cancer Patient-derived Xenografts Gris-Oliver, Albert; Palafox, Marta; Monserrat, Laia; Braso-Maristany, Fara; Odena, Andreu; Sanchez-Guixe, Monica; Ibrahim, Yasir H.; Villacampa, Guillermo; Grueso, Judit; Pars, Mireia; Guzman, Marta; Rodriguez, Olga; Bruna, Alejandra; Hirst, Caroline S.; CLINICAL CANCER RESEARCH 1078-0432 (2020) DOI / 10.1158/1078-0432.ccr-19-3324 Bronze, Green accepted
Mentions   0   Wikipedia   0   News   0   Policy
Article Neoadjuvant eribulin in HER2-negative early-stage breast cancer (SOLTI-1007-NeoEribulin): a multicenter, two-cohort, non-randomized phase II trial Pascual, Tomas; Oliveira, Mafalda; Villagrasa, Patricia; Ortega, Vanesa; Pare, Laia; Bermejo, Begona; Morales, Serafin; Amillano, Kepa; Lopez, Rafael; Galvan, Patricia; Canes, Jordi; Salvador, Fernando; Nuciforo, Paolo; Rubio, Isabel T.; Llombart-Cussac, A NPJ BREAST CANCER (2021) DOI / 10.1038/s41523-021-00351-4 Gold
Mentions   0   Wikipedia   2   News   0   Policy
Article SEOM clinical guidelines in advanced and recurrent breast cancer (2018) Chacon Lopez-Muniz, J. I.; de la Cruz-Merino, L.; Gavila Gregori, J.; Martinez Duenas, E.; Oliveira, M.; Segui Palmer, M. A.; Alvarez Lopez, I.; Antolin Novoa, S.; Bellet Ezquerra, M.; Lopez-Tarruella Cobo, S. CLINICAL & TRANSLATIONAL ONCOLOGY 1699-048X (2019) DOI / 10.1007/s12094-018-02010-w Green published, Hybrid
Mentions   0   Wikipedia   3   News   0   Policy
Article Efficacy of Neratinib Plus Capecitabine in the Subgroup of Patients with Central Nervous System Involvement from the NALA Trial Hurvitz, Sara A.; Saura, Cristina; Oliveira, Mafalda; Trudeau, Maureen E.; Moy, Beverly; Delaloge, Suzette; Gradishar, William; Kim, Sung-Bae; Haley, Barbara; Ryvo, Larisa; Dai, Ming-Shen; Milovanov, Vladimir; Alarcon, Jesus; Kalmadi, Sujith; Cronemberger, ONCOLOGIST 1083-7159 (2021) DOI / 10.1002/onco.13830 Hybrid
Mentions   0   Wikipedia   0   News   0   Policy
Article Immune microenvironment characterisation and dynamics during anti-HER2-based neoadjuvant treatment in HER2-positive breast cancer Griguolo, G.; Serna, G.; Pascual, T.; Fasani, R.; Guardia, X.; Chic, N.; Pare, L.; Pernas, S.; Munoz, M.; Oliveira, M.; Vidal, M.; Llombart-Cussac, A.; Cortes, J.; Galvan, P.; Bermejo, B.; Martinez, N.; Lopez, R.; Morales, S.; Garau, I; Manso, L.; Alarcon, NPJ PRECISION ONCOLOGY (2021) DOI / 10.1038/s41698-021-00163-6 Gold DOAJ
Mentions   0   Wikipedia   1   News   0   Policy
Article Capivasertib, an AKT Kinase Inhibitor, as Monotherapy or in Combination with Fulvestrant in Patients with AKT1(E17K)-Mutant, ER-Positive Metastatic Breast Cancer Smyth, Lillian M.; Tamura, Kenji; Oliveira, Mafalda; Ciruelos, Eva M.; Mayer, Ingrid A.; Sablin, Marie-Paule; Biganzoli, Laura; Ambrose, Helen J.; Ashton, Jack; Barnicle, Alan; Cashell, Des D.; Corcoran, Claire; de Bruin, Elza C.; Foxley, Andrew; Hauser, J CLINICAL CANCER RESEARCH 1078-0432 (2020) DOI / 10.1158/1078-0432.ccr-19-3953 Bronze, Green accepted
Mentions   0   Wikipedia   1   News   0   Policy
Article BEECH: a dose-finding run-in followed by a randomised phase II study assessing the efficacy of AKT inhibitor capivasertib (AZD5363) combined with paclitaxel in patients with estrogen receptor-positive advanced or metastatic breast cancer, and in a PIK3CA m Turner, N. C.; Alarcon, E.; Armstrong, A. C.; Philco, M.; Lopez Chuken, Y. A.; Sablin, M. -P.; Tamura, K.; Gomez Villanueva, A.; Perez-Fidalgo, J. A.; Cheung, S. Y. A.; Corcoran, C.; Cullberg, M.; Davies, B. R.; de Bruin, E. C.; Foxley, A.; Lindemann, J. P ANNALS OF ONCOLOGY 0923-7534 (2019) DOI / 10.1093/annonc/mdz086 Green published, Gold other
Mentions   0   Wikipedia   0   News   0   Policy
Article Biomarker Analysis of the Phase III NALA Study of Neratinib plus Capecitabine versus Lapatinib plus Capecitabine in Patients with Previously Treated Metastatic Breast Cancer Saura, Cristina; Matito, Judit; Oliveira, Mafalda; Wildiers, Hans; Brufksy, Adam M.; Waters, Simon H.; Hurvitz, Sara A.; Moy, Beverly; Kim, Sung-Bae; Gradishar, William J.; Queiroz, Geraldo Silva; Cronemberger, Eduardo; Wallweber, Gerald J.; Bebchuk, Judit CLINICAL CANCER RESEARCH 1078-0432 (2021) DOI / 10.1158/1078-0432.ccr-21-1584 Hybrid, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Palbociclib combined with endocrine therapy in heavily pretreated HR+/HER2(-) advanced breast cancer patients: Results from the compassionate use program in Spain (PALBOCOMP) Manso, Luis; Hernando, Cristina; Galan, Maria; Oliveira, Mafalda; Cabrera, Miguel A.; Bratos, Raquel; Rodriguez, Cesar A.; Ruiz-Borrego, Manuel; Blanch, Salvador; Llombart-Cussac, Antonio; Delgado-Mingorance, Juan I.; Alvarez-Busto, Inaki; Gallegos, Isabel BREAST 0960-9776 (2020) DOI / 10.1016/j.breast.2020.11.005 Gold DOAJ, Green published
Mentions   0   Wikipedia   1   News   0   Policy
Article Final results of the double-blind placebo-controlled randomized phase 2 LOTUS trial of first-line ipatasertib plus paclitaxel for inoperable locally advanced/metastatic triple-negative breast cancer Dent, Rebecca; Oliveira, Mafalda; Isakoff, Steven J.; Im, Seock-Ah; Espie, Marc; Blau, Sibel; Tan, Antoinette R.; Saura, Cristina; Wongchenko, Matthew J.; Xu, NA; Bradley, Denise; Reilly, Sarah-Jayne; Mani, Aruna; Kim, Sung-Bae BREAST CANCER RESEARCH AND TREATMENT 0167-6806 (2021) DOI / 10.1007/s10549-021-06143-5
Mentions   0   Wikipedia   1   News   0   Policy
Review Brain Metastases in HER2-Positive Breast Cancer: Current and Novel Treatment Strategies Garcia-Alvarez, Alejandro; Papakonstantinou, Andri; Oliveira, Mafalda CANCERS (2021) DOI / 10.3390/cancers13122927 Gold DOAJ, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Neratinib plus capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and >= 2 prior HER2-directed regimens Moy, Beverly; Oliveira, Mafalda; Saura, Cristina; Gradishar, William; Kim, Sung-Bae; Brufsky, Adam; Hurvitz, Sara A.; Ryvo, Larisa; Fagnani, Daniele; Kalmadi, Sujith; Silverman, Paula; Delaloge, Suzette; Alarcon, Jesus; Kwong, Ava; Lee, Keun Seok; Ang, Pet BREAST CANCER RESEARCH AND TREATMENT 0167-6806 (2021) DOI / 10.1007/s10549-021-06217-4 Gold other
Mentions   0   Wikipedia   0   News   0   Policy
Article Phase Ib Dose-escalation/Expansion Trial of Ribociclib in Combination With Everolimus and Exemestane in Postmenopausal Women with HR+, HER2- Advanced Breast Cancer Bardia, Aditya; Modi, Shanu; Oliveira, Mafalda; Cortes, Javier; Campone, Mario; Ma, Brigette; Dirix, Luc; Weise, Amy; Hewes, Becker; Diaz-Padilla, Ivan; Han, Yu; Deshpande, Priya; Samant, Tanay S.; Lorenc, Karen Rodriguez; He, Wei; Su, Fei; Chavez-MacGrego CLINICAL CANCER RESEARCH 1078-0432 (2020) DOI / 10.1158/1078-0432.ccr-20-1068 Green accepted
Mentions   0   Wikipedia   0   News   0   Policy
Article FAIRLANE, a double-blind placebo-controlled randomized phase II trial of neoadjuvant ipatasertib plus paclitaxel for early triple-negative breast cancer Oliveira, M.; Saura, C.; Nuciforo, P.; Calvo, I; Andersen, J.; Passos-Coelho, J. L.; Gil Gil, M.; Bermejo, B.; Patt, D. A.; Ciruelos, E.; de la Pena, L.; Xu, N.; Wongchenko, M.; Shi, Z.; Singel, S. M.; Isakoff, S. J. ANNALS OF ONCOLOGY 0923-7534 (2019) DOI / 10.1093/annonc/mdz177 Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article POSEIDON Trial Phase 1b Results: Safety, Efficacy and Circulating Tumor DNA Response of the Beta Isoform-Sparing PI3K Inhibitor Taselisib (GDC-0032) Combined with Tamoxifen in Hormone Receptor Positive Metastatic Breast Cancer Patients Baird, Richard D.; van Rossum, Annelot G. J.; Oliveira, Mafalda; Beelen, Karin; Gao, Meiling; Schrier, Mariette; Mandjes, Ingrid A. M.; Garcia-Corbacho, Javier; Vallier, Anne-Laure; Dougall, Greig; van Werkhoven, Erik; Linossi, Constanza; Kumar, Sanjeev; v CLINICAL CANCER RESEARCH 1078-0432 (2019) DOI / 10.1158/1078-0432.ccr-19-0508 Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article A First-in-Human Phase I Study of the ATP-Competitive AKT Inhibitor Ipatasertib Demonstrates Robust and Safe Targeting of AKT in Patients with Solid Tumors Saura, Cristina; Roda, Desamparados; Rosello, Susana; Oliveira, Mafalda; Macarulla, Teresa; Alejandro Perez-Fidalgo, Jose; Morales-Barrera, Rafael; Manuel Sanchis-Garcia, Juan; Musib, Luna; Budha, Nageshwar; Zhu, Jin; Nannini, Michelle; Chan, Wai Y.; Bohor CANCER DISCOVERY 2159-8274 (2017) DOI / 10.1158/2159-8290.cd-16-0512 Green accepted, Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article PI3K activation promotes resistance to eribulin in HER2-negative breast cancer Gris-Oliver, Albert; Ibrahim, Yasir H.; Rivas, Martin A.; Garcia-Garcia, Celina; Sanchez-Guixe, Monica; Ruiz-Pace, Fiorella; Viaplana, Cristina; Perez-Garcia, Jose M.; Llombart-Cussac, Antonio; Grueso, Judit; Pares, Mireia; Guzman, Marta; Rodriguez, Olga; BRITISH JOURNAL OF CANCER 0007-0920 (2021) DOI / 10.1038/s41416-021-01293-1
Mentions   0   Wikipedia   0   News   0   Policy
Article Circulating Tumor DNA and Biomarker Analyses From the LOTUS Randomized Trial of First-Line Ipatasertib and Paclitaxel for Metastatic Triple-Negative Breast Cancer Wongchenko, Matthew J.; Kim, Sung-Bae; Saura, Cristina; Oliveira, Mafalda; Lipson, Doron; Kennedy, Mark; Greene, Mandy; Breese, Virginia; Mani, Aruna; Xu, NA; Dent, Rebecca JCO PRECISION ONCOLOGY (2020) DOI / 10.1200/po.19.00396
Mentions   0   Wikipedia   0   News   0   Policy
Article A phase Ib, open-label, dose-escalation study of the safety and pharmacology of taselisib (GDC-0032) in combination with either docetaxel or paclitaxel in patients with HER2-negative, locally advanced, or metastatic breast cancer Abramson, Vandana G.; Oliveira, Mafalda; Cervantes, Andres; Wildiers, Hans; Patel, Manish R.; Bauer, Todd M.; Bedard, Philippe L.; Becerra, Carlos; Richey, Stephen; Wei, Michael C.; Reyner, Eric; Bond, John; Cui, Na; Wilson, Timothy R.; Moore, Heather M.; BREAST CANCER RESEARCH AND TREATMENT 0167-6806 (2019) DOI / 10.1007/s10549-019-05360-3
Mentions   0   Wikipedia   0   News   0   Policy
Article Ipatasertib plus paclitaxel for PIK3CA/AKT1/PTEN-altered hormone receptor-positive HER2-negative advanced breast cancer: primary results from cohort B of the IPATunity130 randomized phase 3 trial Turner, Nicholas; Dent, Rebecca A.; O'Shaughnessy, Joyce; Kim, Sung-Bae; Isakoff, Steven J.; Barrios, Carlos; Saji, Shigehira; Bondarenko, Igor; Nowecki, Zbigniew; Lian, Qinshu; Reilly, Sarah-Jayne; Hinton, Heather; Wongchenko, Matthew J.; Kovic, Bruno; Ma BREAST CANCER RESEARCH AND TREATMENT 0167-6806 (2021) DOI / 10.1007/s10549-021-06450-x Hybrid
Mentions   0   Wikipedia   0   News   0   Policy
Article Phase II Study of Taselisib (GDC-0032) in Combination with Fulvestrant in Patients with HER2-Negative, Hormone Receptor-Positive Advanced Breast Cancer Dickler, Maura N.; Saura, Cristina; Richards, Donald A.; Krop, Ian E.; Cervantes, Andres; Bedard, Philippe L.; Patel, Manish R.; Pusztai, Lajos; Oliveira, Mafalda; Cardenas, Alison K.; Cui, Na; Wilson, Timothy R.; Stout, Thomas J.; Wei, Michael C.; Hsu, Je CLINICAL CANCER RESEARCH 1078-0432 (2018) DOI / 10.1158/1078-0432.ccr-18-0613 Bronze, Green accepted
Mentions   0   Wikipedia   0   News   0   Policy
Article Neratinib plus capecitabine for the treatment of advanced HER2-positive breast cancer Oliveira, Mafalda; Garrigos, Laia; Assaf, Juan David; Escriva-de-Romani, Santiago; Saura, Cristina EXPERT REVIEW OF ANTICANCER THERAPY 1473-7140 (2020) DOI / 10.1080/14737140.2020.1807947

Más rankings

InfluScience

Contacto
Cerrar